{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T12:17:41Z","timestamp":1790511461286,"version":"4.1.0"},"reference-count":39,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,1,25]],"date-time":"2006-01-25T00:00:00Z","timestamp":1138147200000},"content-version":"vor","delay-in-days":1607,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of the New York Academy of Sciences"],"published-print":{"date-parts":[[2001,9]]},"abstract":"<jats:p>\n                    <jats:bold>\n                      A\n                      <jats:sc>bstract<\/jats:sc>\n                      :\n                    <\/jats:bold>\n                    The underlying molecular basis of primary cutaneous lymphomas has not yet been clarified. However, abnormalities of cell cycle control genes and well\u2010defined tumor suppressor genes such as p53 are common and may contribute to disease progression and treatment resistance. Biallelic inactivation of tumor suppressor genes usually occurs by a combination of deletion, point mutation, and\/or promotor hypermethylation. The detection of UVB\u2010specific mutations of p53 requires confirmation but may have important implications for the management of patients with mycosis fungoides. Molecular cytogenetic studies have identified common regions of chromosomal deletion and amplification, which suggests the presence and location of genes that are of critical importance in the pathogenesis of cutaneous lymphoma.\n                  <\/jats:p>","DOI":"10.1111\/j.1749-6632.2001.tb03709.x","type":"journal-article","created":{"date-parts":[[2010,7,20]],"date-time":"2010-07-20T15:46:19Z","timestamp":1279640779000},"page":"39-45","source":"Crossref","is-referenced-by-count":23,"title":["Molecular Genetics of Cutaneous Lymphomas"],"prefix":"10.1111","volume":"941","author":[{"given":"SEAN","family":"WHITTAKER","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,1,25]]},"reference":[{"key":"e_1_2_8_2_2","first-page":"354","article-title":"EORTC classification for primary cutaneous lymphomas; a proposal from the Cutaneous Lymphoma Study Group of the European Organization for research and treatment of cancer","volume":"90","author":"Willemze R.","year":"1997","journal-title":"Blood"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(91)90057-6"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(92)90043-7"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.83.14.5214"},{"key":"e_1_2_8_6_2","first-page":"1207","article-title":"Frequent expression of the NPM\u2010ALK chimeric fusion protein in anaplastic large cell lymphoma, lymphohistiocytic type","volume":"150","author":"Pileri S.","year":"1997","journal-title":"Am. J. Pathol."},{"key":"e_1_2_8_7_2","first-page":"325","article-title":"Interphase cytogenetics and its role in molecular diagnostics of solid tumours","volume":"152","author":"Ried T.","year":"1998","journal-title":"Am. J. Pathol."},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12371768"},{"key":"e_1_2_8_9_2","unstructured":"Child F. R. Russell Jones A. Woolford et al.Absence of the t(14;18) chromosomal translocation in primary cutaneous B\u2010cell lymphoma. Br. J. Dermatol In press."},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401475"},{"key":"e_1_2_8_11_2","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1182\/blood.V87.8.3437.bloodjournal8783437","article-title":"The t(2;5) chromosomal translocation is not a common feature of primary cutaneous CD30+ lymphoproliferative disorders: comparison with large cell anaplastic lymphoma of nodal origin","volume":"87","author":"DeCoteau J.","year":"1996","journal-title":"Blood"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-4608(94)00292-4"},{"key":"e_1_2_8_13_2","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1182\/blood.V89.9.3371","article-title":"Recurring structural chromosomal abnormalities in peripheral blood lymphocytes of patients with mycosis fungoides\/S\u00e9zary syndrome","volume":"89","author":"Thangavelu M.","year":"1997","journal-title":"Blood"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-4608(87)90263-9"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.12.5413"},{"key":"e_1_2_8_16_2","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1182\/blood.V89.2.601","article-title":"Relationship of p53, bcl\u20102, and tumour proliferation to clinical drug resistance in non\u2010Hodgkin's lymphomas","volume":"89","author":"Wilson W.","year":"1997","journal-title":"Blood"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1995.tb02488.x"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1995.tb08667.x"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1996.439978.x"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.1999.00507.x"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.22.10124"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12319764"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0560.1999.tb01860.x"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428199409049694"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.314.7092.1483b"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/358015a0"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng0994-15"},{"key":"e_1_2_8_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004030050395"},{"key":"e_1_2_8_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65028-6"},{"key":"e_1_2_8_30_2","unstructured":"Scarisbrick J. A. Woolford E. Calonje et al.Frequent abnormalities of the p15 and p16 genes in mycosis fungoides and S\u00e9zary syndrome. Submitted."},{"key":"e_1_2_8_31_2","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1182\/blood.V86.4.1534.bloodjournal8641534","article-title":"Deletions of the cyclin\u2010dependent inhibitor genes p15 and p16 in non\u2010Hodgkins lymphoma","volume":"86","author":"Gombart A.","year":"1995","journal-title":"Blood"},{"key":"e_1_2_8_32_2","first-page":"837","article-title":"Distinct patterns of inactivation of p15(INK4B) and p16(INK4A) characterise the major types of haematological malignancies","volume":"57","author":"Herman J.","year":"1997","journal-title":"Cancer Res."},{"key":"e_1_2_8_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/5947"},{"issue":"9","key":"e_1_2_8_34_2","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1182\/blood.V95.9.2937.009k15_2937_2942","article-title":"Loss of heterozygosity on 10q and microsatellite instability in advanced stages of primary cutaneous T\u2010cell lymphoma and possible association with homozygous deletion of PTEN","volume":"95","author":"Scarisbrick J.","year":"2000","journal-title":"Blood"},{"key":"e_1_2_8_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12285617"},{"key":"e_1_2_8_36_2","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1182\/blood.V95.3.738.003k21_738_743","article-title":"Large deletions at the t(9;22) breakpoint are common and may identify a poor prognosis subgroup of patients with chronic myeloid leukaemia","volume":"95","author":"Sinclair P.","year":"2000","journal-title":"Blood"},{"key":"e_1_2_8_37_2","first-page":"2775","volume":"60","author":"Jackson A.","year":"2000","journal-title":"Deletion of 6q16.21 in human lymphoid malignancies: a mapping and deletion analysis. Cancer Res."},{"key":"e_1_2_8_38_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5600444"},{"issue":"1","key":"e_1_2_8_39_2","article-title":"Genes, chromosomes and cutaneous T\u2010cell lymphoma","volume":"37","author":"Mao X.","year":"2000","journal-title":"J. Med. Genet."},{"key":"e_1_2_8_40_2","unstructured":"Reference not provided."}],"container-title":["Annals of the New York Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1749-6632.2001.tb03709.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1749-6632.2001.tb03709.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T11:30:18Z","timestamp":1695641418000},"score":1,"resource":{"primary":{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1749-6632.2001.tb03709.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,9]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,9]]}},"alternative-id":["10.1111\/j.1749-6632.2001.tb03709.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1749-6632.2001.tb03709.x","archive":["Portico"],"relation":{},"ISSN":["0077-8923","1749-6632"],"issn-type":[{"value":"0077-8923","type":"print"},{"value":"1749-6632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,9]]}}}